These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1883110)

  • 1. [Ornithine transcarbamylase deficiency. Biochemical studies in the diagnosis of 4 cases and the identification of carriers].
    Briones Godino P; Vilaseca Busca MA; Alvarez Dominguez L; Rodes Monegal M; Campistol Plana J
    An Esp Pediatr; 1991 May; 34(5):360-4. PubMed ID: 1883110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
    Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
    Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
    Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
    Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of ornithine transcarbamylase deficiency.
    Batshaw ML
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):4-6. PubMed ID: 3981367
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prenatal diagnosis of ornithine transcarbamylase deficiency using a DNA marker analysis].
    Schwartz M; Skovby F; Christensen E; Christensen NC
    Ugeskr Laeger; 1988 Oct; 150(44):2641-3. PubMed ID: 3201597
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
    Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
    N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ornithine transcarbamylase deficiency: case report and review.
    Bueno JD; Lutz R; Cho S
    Kans Med; 1995; 96(3):135-8. PubMed ID: 8583741
    [No Abstract]   [Full Text] [Related]  

  • 9. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
    Pridmore CL; Clarke JT; Blaser S
    J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
    Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
    Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice].
    Qureshi IA; Letarte J; Lebel S; Ouellet R
    Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of immunocytochemical analysis of a duodenal biopsy specimen to identify a carrier of ornithine transcarbamylase deficiency.
    Hamano Y; Kodama H; Fujikawa Y; Tanaka Y; Nishimura K; Yanagisawa M
    N Engl J Med; 1988 Jun; 318(23):1521-3. PubMed ID: 3367962
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ornithine-transcarbamylase deficiency: prognostic difficulties].
    Sanjurjo Crespo P; Sasieta Altuna M; Rubio Zamora V; Prats Viñas JM; Vallo Boado A
    An Esp Pediatr; 1991 Dec; 35(6):407-8. PubMed ID: 1793191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family.
    Ausems MG; Bakker E; Berger R; Duran M; van Diggelen OP; Keulemans JL; de Valk HW; Kneppers AL; Dorland L; Eskes PF; Beemer FA; Poll-The BT; Smeitink JA
    Am J Med Genet; 1997 Jan; 68(2):236-9. PubMed ID: 9028466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urea cycle disorders in Thai infants: a report of 5 cases.
    Wasant P; Srisomsap C; Liammongkolkul S; Svasti J
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S720-31. PubMed ID: 12403252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and genetic studies of a family with ornithine transcarbamylase deficiency.
    Goldstein AS; Hoogenraad NJ; Johnson JD; Fukanaga K; Swierczewski E; Cann HM; Sunshine P
    Pediatr Res; 1974 Jan; 8(1):5-12. PubMed ID: 4809308
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural history of symptomatic partial ornithine transcarbamylase deficiency.
    Rowe PC; Newman SL; Brusilow SW
    N Engl J Med; 1986 Feb; 314(9):541-7. PubMed ID: 3945292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal initial adult-onset presentation of urea cycle defect.
    Lien J; Nyhan WL; Barshop BA
    Arch Neurol; 2007 Dec; 64(12):1777-9. PubMed ID: 18071043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-chain hydroxyacyl-coenzyme A dehydrogenase deficiency presenting as unexpected infant death: A family study.
    Treacy EP; Lambert DM; Barnes R; Boriack RL; Vockley J; O'brien LK; Jones PM; Bennett MJ
    J Pediatr; 2000 Aug; 137(2):257-9. PubMed ID: 10931422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variants of inborn errors of metabolism with late onset but nevertheless life threatening course].
    Plöchl E; Plöchl W; Wermuth B; Roscher AA
    Klin Padiatr; 2001; 213(5):261-5. PubMed ID: 11582523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.